Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Telmisartan Market: By Strength: 20mg, 40mg, 80mg; By Condition: Hypertension, Stroke, Cardiac Arrest, Others; By Distribution Channel: Hospital Pharmacies, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Telmisartan Market Outlook
The global telmisartan market attained a value of about USD 3,574 million in 2020. The market is further expected to grow at a CAGR of 3.5% during the forecast period of 2022-2027 to reach approximately USD 4,393 million by 2026.
Surge in Chronic Diseases to Bolster the Market Growth of Telmisartan
The global market for telmisartan is being driven by the prevalence and rise in diseases like hypertension and other cardiac diseases. The advent of the coronavirus forced governments across the world to implement stringent lockdown rules, owing to which many companies were impelled to cut down salaries and jobs. As a result of elongated periods of unemployment and other pandemic-induced stress, there has been a substantial rise in cardiac diseases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Telmisartan works against high blood pressure by being effective in gene modification for insulin sensitisation and regulating glucose and lipid metabolism. Furthermore, in addition to stress, other factors such as spur in the geriatric population and unhealthy lifestyle are also giving rise to diseases like chronic diabetes and other diseases, which augment the market growth for telmisartan. The drug is used to lower the risk of heart attacks and kidney failures in patients with diabetes, hence invigorating the industry growth.
Telmisartan: Industry Definition and Segmentation
Telmisartan refers to a non-peptide angiotensin receptor blocker/ ARB, popularly used as a prescription drug for treating cardiovascular disorders. The drug functions to relax the blood vessels and promote the healthy functioning of the kidneys.
The market, based on strength, can be segmented into:
- 20mg
- 40mg
- 80mg
Based on condition, the market can be divided into:
- Hypertension
- Stroke
- Cardiac Arrest
- Others
On the basis of distribution channels, the market is classified into:
- Hospital Pharmacies
- Retail Pharmacies and Drug Stores
- Online
The EMR report looks into the regional markets of telmisartan like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Research and Development (R&D) in the Pharmaceutical Sector to Augment Market Growth
The robust growth of the pharmaceutical sector is supplementing the market growth of telmisartan to treat chronic diseases like those related to the cardiovascular system. Significant contributions towards research and development (R&D) projects to explore the various benefits of telmisartan in the treatment of diabetic nephropathy and other kidney disorders are generating growth opportunities for the industry growth. In addition, pharmaceutical manufacturers are working towards the development of generic versions of telmisartan medications to provide cost-effective treatment to patients suffering from hypertension and other cardiovascular diseases, consequently augmenting the market growth.
Furthermore, owing to the presence of prominent pharmaceutical players and well-funded research centres in North America, the region is estimated to dominate the market growth of telmisartan over the forecast period. The growth in the region can also be attributed to the prevalence of chronic diseases due to unhealthy lifestyles. Thus, such factors are contributing to the growth of the telmisartan industry.
Key Industry Players in the Global Telmisartan Market
The report presents a detailed analysis of the following key players in the global telmisartan market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions.
- Novartis AG
- Astellas Pharma Inc.
- Nippon Boehringer Ingelheim
- Abbott
- Hema Pharmaceuticals Pvt. Ltd.
- Pfizer Inc.
- Others
The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Strength, Condition, Distribution Channel, Region |
| Breakup by Strength | 20mg, 40mg, 80mg |
| Breakup by Condition | Hypertension, Stroke, Cardiac Arrest, Others |
| Breakup by Distribution Channel | Hospital Pharmacies, Retail Pharmacies and Drug Stores, Online |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Novartis AG, Astellas Pharma Inc., Nippon Boehringer Ingelheim, Abbott, Hema Pharmaceuticals Pvt. Ltd., Pfizer Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Telmisartan Market Analysis
8.1 Key Industry Highlights
8.2 Global Telmisartan Historical Market (2017-2021)
8.3 Global Telmisartan Market Forecast (2022-2027)
8.4 Global Telmisartan Market by Strength
8.4.1 20mg
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 40mg
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 80mg
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.5 Global Telmisartan Market by Condition
8.5.1 Hypertension
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Stroke
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Cardiac Arrest
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Others
8.6 Global Telmisartan Market by Distribution Channel
8.6.1 Hospital Pharmacies
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Retail Pharmacies and Drug Stores
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Online
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.7 Global Telmisartan Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Novartis AG
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Astellas Pharma Inc.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Nippon Boehringer Ingelheim
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Abbott
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Hema Pharmaceuticals Pvt. Ltd.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Pfizer Inc.
11.2.6.1 Company Overview
11.2.6.2 Product Portfolio
11.2.6.3 Demographic Reach and Achievements
11.2.6.4 Certifications
11.2.7 Others
12 Industry Events and Developments
Additional Customisations Available
1 Manufacturing Process
1.1 Overview
1.2 Detailed Process Flow
1.3 Operation Involved
List of Figures and Tables
1. Global Telmisartan Market: Key Industry Highlights, 2016 and 2026
2. Global Telmisartan Historical Market: Breakup by Strength (USD Million), 2017-2021
3. Global Telmisartan Market Forecast: Breakup by Strength (USD Million), 2022-2027
4. Global Telmisartan Historical Market: Breakup by Condition (USD Million), 2017-2021
5. Global Telmisartan Market Forecast: Breakup by Condition (USD Million), 2022-2027
6. Global Telmisartan Historical Market: Breakup by Distribution Channel (USD Million), 2017-2021
7. Global Telmisartan Market Forecast: Breakup by Distribution Channel (USD Million), 2022-2027
8. Global Telmisartan Historical Market: Breakup by Region (USD Million), 2017-2021
9. Global Telmisartan Market Forecast: Breakup by Region (USD Million), 2022-2027
10. North America Telmisartan Historical Market: Breakup by Country (USD Million), 2017-2021
11. North America Telmisartan Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Europe Telmisartan Historical Market: Breakup by Country (USD Million), 2017-2021
13. Europe Telmisartan Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Asia Pacific Telmisartan Historical Market: Breakup by Country (USD Million), 2017-2021
15. Asia Pacific Telmisartan Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Latin America Telmisartan Historical Market: Breakup by Country (USD Million), 2017-2021
17. Latin America Telmisartan Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Middle East and Africa Telmisartan Historical Market: Breakup by Country (USD Million), 2017-2021
19. Middle East and Africa Telmisartan Market Forecast: Breakup by Country (USD Million), 2022-2027
20. Global Telmisartan Market Structure
Key Questions Answered in the Report
The global telmisartan market attained a value of nearly USD 3,574 million in 2020.
The market is projected to grow at a CAGR of 3.5% in the forecast period of 2022-2027.
The market is estimated to witness healthy growth in the forecast period of 2022-2027 to reach about USD 4,393 million by 2026.
The telmisartan industry is being driven by the rise in prevalence of cardiovascular diseases like hypertension due to pandemic-induced stress, unhealthy lifestyle, and a rise in geriatric population.
Investments in the research and development (R&D) projects to explore the development of telmisartan in the treatment of diabetes is anticipated to propel the market growth.
The major regional markets for telmisartan are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
On the basis of strength, the market can be categorised into 20mg, 40mg, and 80mg.
Based on condition, the market can be segmented into hypertension, stroke, and cardiac arrest, among others.
The major distribution channels of telmisartan include hospital pharmacies, retail pharmacies and drug stores, and online channels.
The major players in the industry are Novartis AG, Astellas Pharma Inc., Nippon Boehringer Ingelheim, Abbott, Hema Pharmaceuticals Pvt. Ltd., and Pfizer Inc, among others.
Analyst Review
The global telmisartan market attained a value of about USD 3,574 million in 2020, driven by the rising cases of hypertension and cardiovascular diseases. Aided by the robustly growing pharmaceutical sector, the market is expected to grow at a CAGR of 3.5% in the forecast period of 2022-2027 to reach nearly USD 4,393 million by 2026.
EMR’s meticulous research methodology delves deep into the market covering the macro and micro aspects of the industry. The market, on the basis of strength, can be divided into 20mg, 40mg, and 80mg. Based on condition, the market can be divided into hypertension, stroke, and cardiac arrest, among others. Based on distribution channels, the market can be classified into hospital pharmacies, retail pharmacies and drug stores, and online channels, among others. The major regional markets for telmisartan are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa. They key players in the industry are Novartis AG, Astellas Pharma Inc., Nippon Boehringer Ingelheim, Abbott, Hema Pharmaceuticals Pvt. Ltd., and Pfizer Inc, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global oral antibiotics market attained a value of over USD 18,365.8 million in 2021, driven by the extensive use of oral antibiotics for the treatment of infectious diseases. Aided by the growing...
The Asia Pacific vaccine market attained a value of nearly USD 3.92 billion in 2021, driven by the robust growth of the healthcare sector. Aided by the increasing research and development (R&D) activi...
The global microencapsulation market attained a value of about USD 9.52 billion in 2021, driven by the advancements in the pharmaceutical and nutraceutical industries. Aided by growing inclination tow...
The global anti-infectives market attained a value of about USD 118.36 billion in 2021, driven by the rising prevalence of infectious diseases. Aided by large scale investments into the pharmaceutical...
The global liposomal doxorubicin market attained a value of more than USD 1,100 million in 2021, driven by the increase in breast and ovarian cancer cases, as well as increased awareness of the advant...
NEWSLETTER